SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000076
Filing Date
2024-02-26
Accepted
2024-02-26 07:05:41
Documents
92
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cldx-20231231x10k.htm   iXBRL 10-K 2299629
2 EX-1.1 cldx-20231231xex1d1.htm EX-1.1 363935
3 EX-5.1 cldx-20231231xex5d1.htm EX-5.1 10222
4 EX-21.1 cldx-20231231xex21d1.htm EX-21.1 6286
5 EX-23.1 cldx-20231231xex23d1.htm EX-23.1 5052
6 EX-31.1 cldx-20231231xex31d1.htm EX-31.1 13767
7 EX-31.2 cldx-20231231xex31d2.htm EX-31.2 15216
8 EX-32 cldx-20231231xex32.htm EX-32 9847
9 EX-97 cldx-20231231xex97.htm EX-97 29767
10 GRAPHIC cldx-20231231x10k002.jpg GRAPHIC 32087
  Complete submission text file 0001410578-24-000076.txt   8867514

Data Files

Seq Description Document Type Size
11 EX-101.SCH cldx-20231231.xsd EX-101.SCH 50884
12 EX-101.CAL cldx-20231231_cal.xml EX-101.CAL 64770
13 EX-101.DEF cldx-20231231_def.xml EX-101.DEF 206581
14 EX-101.LAB cldx-20231231_lab.xml EX-101.LAB 521724
15 EX-101.PRE cldx-20231231_pre.xml EX-101.PRE 378784
94 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20231231x10k_htm.xml XML 1229587
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 24673521
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)